13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 23 holding rows worth $710,313,000.
- Accession
- 0000950123-19-002137
- Filer
- CIK 1388325
- Filed
- 2019-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, 23 entries on the cover page, a total value of $710,313,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $710,313,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INOGEN INC | 45780L104 | COM | 3,549,320 | $440,719,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 605,266 | $33,998,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 1,308,037 | $23,859,000 | thousands by filing date | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 654,549 | $22,831,000 | thousands by filing date | |
| SI BONE INC | 825704109 | COM | 892,684 | $18,648,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 420,293 | $18,304,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,867,870 | $17,894,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 3,100,000 | $17,143,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 450,714 | $16,271,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 4,420,516 | $16,223,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 1,993,746 | $14,335,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 525,000 | $10,159,000 | thousands by filing date | |
| ENTASIS THERAPEUTICS HLDGS I | 293614103 | COM | 2,181,843 | $8,880,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 87,481 | $8,026,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 175,000 | $7,394,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 740,740 | $7,148,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 502,795 | $7,039,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 4,703,720 | $6,867,000 | thousands by filing date | |
| MENLO THERAPEUTICS INC | 586858102 | COM | 1,269,145 | $5,229,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 135,009 | $4,049,000 | thousands by filing date | |
| Citigroup Inc. | 172967424 | COM | 52,500 | $2,733,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC COM | 903214104 | COM | 569,031 | $2,504,000 | thousands by filing date | |
| WRIGHT MED GROUP N V | N96617126 | RIGHT 03/01/2019 | 4,622,032 | $60,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-19-002137 | this filing | 2019-02-14 | acceptance time not in the bulk data set |